2018
London, UK, 21 December 2018 An estimated 500 patients per year in France could be eligible for treatment with TheraSphere® BTG plc (LSE: BTG), a global specialist healthcare company, today...
03 December 2018 BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device –...
London, UK, 13 November 2018 BTG plc (LSE: BTG), the global healthcare company, today announces its Interim Results for the six months ended 30 September 2018. Click here to download the statement...
Bothell, WA, 07 November 2018 BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances...
06 November 2018 First commercial units are shipped to Europe BTG plc (LSE: BTG), the global healthcare company, announced today that the first EKOS™ CU 4.0 units have been shipped from BTG’s...
04 October 2018 Good first half performance, updating full year sales growth guidance BTG plc (LSE: BTG), the global healthcare company, provides the following update for the six months ended 30...
04 October 2018 BTG plc (LSE: BTG), the global healthcare company, announces that Garry Watts has informed the Board that he wishes to retire as Chairman and Non-executive Director of the Company....
26 September 2018 BTG plc (LSE: BTG) today announced a policy for replacement of expired vials of CroFab® Crotalidae Polyvalent Immune Fab (Ovine), allowing customers to return the product for...
London, UK, 20 September 2018 The ICEfx™ Cryoablation system is a compact and powerful console, offering predictable, reliable performance with seamless therapy delivery and exceptional ease of...
London, 07 September 2018 BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company focused on the...
09 August 2018 BTG plc (LSE: BTG), the global specialist healthcare company, today announces that PneumRx® has received confirmation from the US Food and Drug Administration (FDA) that the...
Bothell, WA, 23 July 2018 BTG plc (LSE: BTG), the global healthcare company, highlighted the publication of OPTALYSE PE trial results in JACC: Cardiovascular Interventions. The published findings...
18 July 2018 BTG plc (LSE: BTG), the global specialist healthcare company, provides the following update ahead of its Annual General Meeting, which is being held today at 10.30am at the offices of...
Bothell, WA, 21 June 2018 BTG plc (LSE: BTG), the global healthcare company, today announced at the annual PERT Consortium™ Meeting in Nashville, TN, a strategic partnership with the PERT...
19 June 2018 Starting with the 2018/19 financial year, BTG will change its presentational currency to the US Dollar. This change is reflective of the fact that the majority of the Group’s...
Result of FDA Advisory Committee vote on Elevair™ for the treatment of severe emphysema
15 June 2018 BTG plc (LSE: BTG), the global specialist healthcare company, notes that the US Food & Drug Administration’s (FDA’s) Anesthesiology and Respiratory Therapy Devices Panel of the...
London, UK, 11 June 2018 Recruitment begins in 7 European Countries BTG plc (LSE: BTG), the global healthcare company, today announces the start of ELEVATE: A randomizEd ControlLed Study of PnEumRx™
London, UK, 15 May 2018 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its final results for the year ended 31 March 2018. Click here to download the results release...
Bothell, WA, 27 April 2018 BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and...
London, UK, 05 April 2018 BTG plc (LSE: BTG), the global healthcare company, provides the following update for the year ended 31 March 2018. BTG has delivered a good financial performance for the...
Washington, D.C., 04 April 2018 The Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, and BTG plc (LSE:...
Mexico, 21 February 2018 BTG plc (LSE: BTG), a global specialist healthcare company, announced the first patient in Latin America in Mexico was treated with TheraSphere® – a treatment for...
Bothell, Washington, 06 February 2018 BTG plc (LSE: BTG), the global healthcare company, today highlighted OPTALYSE PE one year trial results, presented at the International Society on...
United Kingdom, 23 January 2018 BTG plc (LSE: BTG) the specialist healthcare company, today announces the appointment of Anne Thorburn as a non-executive director of the Board and member of the...